Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

296 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Sodium-Glucose Cotransporter 2 Inhibitors in Patients with Diabetes and Coronary Artery Disease: Translating the Benefits of the Molecular Mechanisms of Gliflozins into Clinical Practice.
Cesaro A, Acerbo V, Vetrano E, Signore G, Scherillo G, Rotolo FP, De Michele G, Scialla F, Raucci G, Panico D, Gragnano F, Moscarella E, Galiero R, Caturano A, Ruggiero R, Sasso FC, Calabrò P. Cesaro A, et al. Int J Mol Sci. 2023 Apr 30;24(9):8099. doi: 10.3390/ijms24098099. Int J Mol Sci. 2023. PMID: 37175805 Free PMC article.
The Role of von Willebrand Factor in Vascular Inflammation: From Pathogenesis to Targeted Therapy.
Gragnano F, Sperlongano S, Golia E, Natale F, Bianchi R, Crisci M, Fimiani F, Pariggiano I, Diana V, Carbone A, Cesaro A, Concilio C, Limongelli G, Russo M, Calabrò P. Gragnano F, et al. Among authors: cesaro a. Mediators Inflamm. 2017;2017:5620314. doi: 10.1155/2017/5620314. Epub 2017 May 28. Mediators Inflamm. 2017. PMID: 28634421 Free PMC article. Review.
Adherence to proprotein convertase subtilisin/kexin 9 inhibitors in high cardiovascular risk patients: an Italian single-center experience.
Gragnano F, Natale F, Concilio C, Fimiani F, Cesaro A, Sperlongano S, Crisci M, Limongelli G, Calabrò R, Russo M, Golia E, Calabrò P. Gragnano F, et al. Among authors: cesaro a. J Cardiovasc Med (Hagerstown). 2018 Feb;19(2):75-77. doi: 10.2459/JCM.0000000000000611. J Cardiovasc Med (Hagerstown). 2018. PMID: 29251697 No abstract available.
Lomitapide in homozygous familial hypercholesterolemia: cardiology perspective from a single-center experience.
Sperlongano S, Gragnano F, Natale F, D'Erasmo L, Concilio C, Cesaro A, Golia E, Crisci M, Sperlongano R, Fimiani F, Russo M, Arca M, Limongelli G, Calabrò P. Sperlongano S, et al. Among authors: cesaro a. J Cardiovasc Med (Hagerstown). 2018 Mar;19(3):83-90. doi: 10.2459/JCM.0000000000000620. J Cardiovasc Med (Hagerstown). 2018. PMID: 29389816
Letter by Calabrò et al Regarding Article, "Low-Density Lipoprotein Cholesterol Lowering With Evolocumab and Outcomes in Patients With Peripheral Artery Disease: Insights From the FOURIER Trial (Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk)".
Calabrò P, Gragnano F, Cesaro A. Calabrò P, et al. Among authors: cesaro a. Circulation. 2018 Jul 10;138(2):218-219. doi: 10.1161/CIRCULATIONAHA.117.033137. Circulation. 2018. PMID: 29986968 No abstract available.
Functional assessment of coronary stenosis: an overview of available techniques. Is quantitative flow ratio a step to the future?
Cesaro A, Gragnano F, Di Girolamo D, Moscarella E, Diana V, Pariggiano I, Alfieri A, Perrotta R, Golino P, Cesaro F, Mercone G, Campo G, Calabrò P. Cesaro A, et al. Among authors: cesaro f. Expert Rev Cardiovasc Ther. 2018 Dec;16(12):951-962. doi: 10.1080/14779072.2018.1540303. Epub 2018 Nov 1. Expert Rev Cardiovasc Ther. 2018. PMID: 30352515 Review.
296 results